The FDA-approved dosing schedules are based on extensive pharmacokinetic and pharmacodynamic studies demonstrating the dose-response relationship for both efficacy and safety endpoints
Ivm patients following the Ivm Protocol lost an average of 46% more weight compared to traditional GLP-1 programs, thanks to this personalized, data-driven approach
Schedule a consultation today to find out if Semaglutide or Tirzepatide is right for you and take the first step toward a healthier, more confident you
Running too many compounds at once
Although MT-II is not approved for human use, it is under active research for potential uses in skin tanning and sexual health [6, 7]
If youre 40+ and seeing or feeling signs of aging, or if youre younger and thinking proactively, NAD+ and 5-Amino-1MQ combination therapy is worth exploring